CN Stock MarketDetailed Quotes

688193 Shanghai Rendu Biotechnology

Watchlist

42.38
-0.54-1.26%

Market Closed Nov 29 15:00 CST

1.70BMarket Cap79.66P/E (TTM)

Shanghai Rendu Biotechnology Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

Assets

Current assets

Money funds

-65.52%235.08M

-16.22%242.03M

115.90%589.91M

103.91%609.57M

-5.86%681.83M

-65.86%288.9M

-68.76%273.24M

51.02%298.93M

--724.29M

388.10%846.2M

Transactional financial assets

238.92%442.78M

-14.49%446.03M

-92.73%40.02M

-90.54%50.21M

18.77%130.64M

--521.63M

--550.29M

--530.98M

--110M

----

Notes receivable and accounts receivable

-18.78%66.14M

-16.10%72.4M

-21.18%69.7M

-26.51%77.07M

-19.30%81.43M

-12.85%86.29M

13.56%88.43M

89.56%104.86M

--100.9M

133.12%99.01M

-Notes receivable

----

--100K

--259.95K

----

--180K

-Accounts receivable

-18.78%66.14M

-16.10%72.4M

-21.29%69.6M

-26.76%76.81M

-19.15%81.43M

-12.69%86.29M

13.82%88.43M

89.56%104.86M

--100.72M

132.69%98.83M

Other receivables (including interest and dividends)

-17.72%1.31M

-18.10%986.1K

-42.99%957.67K

-3.88%1.1M

30.85%1.59M

229.01%1.2M

135.66%1.68M

-70.48%1.15M

--1.21M

-83.40%365.94K

-Accrued interest receivable

----

--300.46K

--24.45K

----

-Other receivable

----

-16.40%986.1K

----

-3.88%1.1M

----

222.32%1.18M

----

-70.48%1.15M

----

-83.40%365.94K

Advance payment

46.82%4.53M

28.03%3.18M

61.35%3.54M

-36.72%2.64M

-38.57%3.09M

-68.37%2.48M

-74.10%2.19M

-21.29%4.17M

--5.03M

173.35%7.85M

Inventories

-22.37%24.2M

-19.14%25.19M

-14.23%27.03M

1.07%28.6M

10.62%31.17M

17.63%31.15M

57.13%31.51M

45.94%28.29M

--28.18M

10.14%26.48M

Receivable financing

----

124.87%775.79K

103.16%532.68K

--538.2K

--96.6K

--345K

45.67%262.2K

----

Other current assets

2,131.58%83.05M

1,769.64%79.6M

3,747.60%155.29M

3,188.94%129.43M

-32.36%3.72M

-32.07%4.26M

725.12%4.04M

642.81%3.94M

--5.5M

323.45%6.27M

Total current assets

-8.24%857.08M

-7.11%869.41M

-6.78%887.22M

-7.55%899.14M

-4.22%934.01M

-5.09%936.01M

-3.12%951.72M

244.23%972.58M

--975.12M

300.18%986.17M

Non Current assets

Fixed assets

----

-4.41%83.74M

----

-5.94%85.8M

----

-0.99%87.6M

----

9.43%91.21M

----

15.91%88.48M

Constru in process

----

--218.83K

----

Intangible assets

-4.45%466.94K

-4.07%524.25K

-33.55%401.57K

-32.06%449.89K

-31.31%488.7K

7.30%546.52K

9.26%604.33K

10.92%662.15K

--711.5K

-1.59%509.32K

Long deferred expense

-7.24%6.97M

-6.37%7.19M

126.02%7.81M

122.63%8.3M

82.45%7.51M

131.94%7.68M

-4.36%3.46M

-4.86%3.73M

--4.12M

152.73%3.31M

Deferred tax assets

3.54%13.14M

9.22%13.47M

14.99%13.34M

34.51%12.96M

154.71%12.69M

167.21%12.33M

198.59%11.6M

198.33%9.63M

--4.98M

21.92%4.62M

Usufruct assets

-36.49%4.84M

-33.38%5.53M

-30.86%6.23M

-28.65%6.92M

-9.03%7.62M

144.08%8.3M

134.15%9.01M

126.11%9.7M

--8.37M

-34.31%3.4M

Other non current assets

7,505.62%41.8M

5,130.29%41.41M

2,080.89%41.21M

3,314.34%41.15M

73.84%549.6K

-28.29%791.72K

0.37%1.89M

76.59%1.21M

--316.16K

83.34%1.1M

Adjustment items of non current assets

----

--0.01

----

Total non current assets

30.35%148.21M

29.70%152.09M

33.97%153.61M

33.95%155.57M

2.05%113.71M

15.62%117.26M

13.07%114.66M

20.89%116.14M

--111.43M

15.61%101.42M

Total assets

-4.05%1.01B

-3.02%1.02B

-2.40%1.04B

-3.12%1.05B

-3.57%1.05B

-3.16%1.05B

-1.60%1.07B

187.56%1.09B

206.34%1.09B

225.47%1.09B

Liabilities

Current liabilities

Notes payable and accounts payable

-6.19%5.24M

-34.39%3.82M

7.44%3.91M

-64.03%4.09M

-44.09%5.58M

-71.42%5.82M

-78.26%3.63M

15.67%11.38M

--9.98M

172.18%20.37M

-Accounts payable

-6.19%5.24M

-34.39%3.82M

7.44%3.91M

-64.03%4.09M

-44.09%5.58M

-71.42%5.82M

-78.26%3.63M

15.67%11.38M

--9.98M

172.18%20.37M

Contract liabilities

-34.59%2.88M

-14.85%3.84M

-39.97%3.99M

-23.91%5.58M

-44.52%4.41M

-33.30%4.51M

-21.99%6.65M

-20.50%7.33M

--7.95M

-33.12%6.76M

Salaries payable

-3.65%9.3M

-12.79%8.95M

-23.49%8.34M

-24.33%12.89M

-22.65%9.65M

-12.34%10.27M

0.37%10.91M

27.54%17.04M

--12.47M

87.28%11.71M

Taxs payable

0.26%1.12M

12.93%1.05M

42.27%1.79M

-12.75%1.55M

-79.72%1.12M

-77.94%928.32K

-81.42%1.26M

-35.87%1.77M

--5.53M

251.73%4.21M

Other payable (including interest and dividends)

9.48%48.07M

4.78%52.16M

-5.83%51.88M

-7.11%51.28M

-18.75%43.9M

-4.20%49.79M

0.31%55.09M

89.82%55.2M

--54.03M

75.55%51.97M

-Other payable

----

4.78%52.16M

----

-7.11%51.28M

----

-4.20%49.79M

----

89.82%55.2M

----

75.55%51.97M

Non current liabilities due within one year

276.62%2.57M

45.99%2.91M

14.78%2.5M

12.48%2.93M

-64.27%683.71K

13.67%1.99M

36.74%2.18M

38.68%2.6M

--1.91M

62.99%1.75M

Other current liabilities

-35.70%111.35K

-1.49%139.82K

-11.35%147.41K

-5.28%131.79K

--173.17K

-58.80%141.94K

-67.61%166.28K

-17.71%139.14K

----

-49.06%344.48K

Total current liabilities

5.76%69.29M

-0.78%72.87M

-9.17%72.56M

-17.82%78.45M

-28.69%65.52M

-24.37%73.44M

-20.05%79.89M

43.97%95.46M

--91.88M

72.22%97.11M

Current liabilities

Estimate liabilities

576.40%31.61K

-87.81%3.14K

----

-74.14%11.8K

--4.67K

-82.43%25.79K

-82.11%42.28K

-81.05%45.63K

----

-78.22%146.82K

Deferred tax liabilities

----

--1.2M

--1.35M

--1.34M

--1.72M

----

Long term deferred income

-71.75%6.4M

-68.19%7.21M

-63.30%8.32M

-57.55%9.42M

2.09%22.66M

0.00%22.2M

--22.2M

4.23%22.2M

Lease liabilities

-67.35%2.29M

-53.44%2.8M

-42.30%3.88M

-48.28%4.09M

13.39%7.01M

223.77%6.01M

230.19%6.72M

274.34%7.91M

--6.18M

-48.36%1.86M

Total non current liabilities

-71.75%8.72M

-66.68%10.01M

-60.36%12.2M

-57.56%13.53M

8.79%30.88M

24.13%30.04M

25.71%30.76M

29.82%31.87M

--28.38M

-5.34%24.2M

Total liabilities

-19.07%78.02M

-19.91%82.88M

-23.40%84.76M

-27.77%91.97M

-19.84%96.4M

-14.69%103.49M

-11.05%110.65M

40.15%127.34M

46.15%120.26M

48.02%121.31M

Shareholders equity

Paid-in capital

0.00%40M

33.33%40M

--40M

33.33%40M

Capital reserve funds

-0.11%777.48M

-0.27%776.22M

-0.32%774.96M

-0.33%773.7M

-0.14%778.3M

-0.43%778.3M

-0.36%777.47M

473.13%776.23M

--779.37M

494.92%781.64M

Surplus reserve funds

13.60%12.92M

0.00%11.38M

--11.38M

89.52%11.38M

Retained profit

9.79%133.3M

11.20%132.96M

9.20%140.17M

1.27%136.46M

-10.18%121.41M

-10.34%119.56M

0.10%128.36M

20.94%134.75M

--135.18M

56.48%133.34M

Less:Treasury stock

--35.66M

--23.38M

--11.71M

----

Other composite income

-427.90%-763.28K

-119.07%-103.88K

81.17%-279.93K

64.06%-348.6K

-34.53%232.78K

722.06%544.82K

-191.95%-1.49M

-99.34%-969.95K

--355.56K

77.83%-87.58K

Shareholders equity without minority interests

-2.53%927.28M

-1.18%938.62M

0.04%956.07M

0.14%962.74M

-1.55%951.32M

-1.71%949.78M

-0.38%955.72M

234.11%961.38M

254.73%966.28M

283.13%966.27M

Total shareholder equity

-2.53%927.28M

-1.18%938.62M

0.04%956.07M

0.14%962.74M

-1.55%951.32M

-1.71%949.78M

-0.38%955.72M

234.11%961.38M

254.73%966.28M

283.13%966.27M

Total liabilityies and equity

-4.05%1.01B

-3.02%1.02B

-2.40%1.04B

-3.12%1.05B

-3.57%1.05B

-3.16%1.05B

-1.60%1.07B

187.56%1.09B

206.34%1.09B

225.47%1.09B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Lixin Certified Public Accountants (Special General Partnership)

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022
Assets
Current assets
Money funds	-65.52%235.08M	-16.22%242.03M	115.90%589.91M	103.91%609.57M	-5.86%681.83M	-65.86%288.9M	-68.76%273.24M	51.02%298.93M	--724.29M	388.10%846.2M
Transactional financial assets	238.92%442.78M	-14.49%446.03M	-92.73%40.02M	-90.54%50.21M	18.77%130.64M	--521.63M	--550.29M	--530.98M	--110M	----
Notes receivable and accounts receivable	-18.78%66.14M	-16.10%72.4M	-21.18%69.7M	-26.51%77.07M	-19.30%81.43M	-12.85%86.29M	13.56%88.43M	89.56%104.86M	--100.9M	133.12%99.01M
-Notes receivable	----	----	--100K	--259.95K	----	----	----	----	--180K	--180K
-Accounts receivable	-18.78%66.14M	-16.10%72.4M	-21.29%69.6M	-26.76%76.81M	-19.15%81.43M	-12.69%86.29M	13.82%88.43M	89.56%104.86M	--100.72M	132.69%98.83M
Other receivables (including interest and dividends)	-17.72%1.31M	-18.10%986.1K	-42.99%957.67K	-3.88%1.1M	30.85%1.59M	229.01%1.2M	135.66%1.68M	-70.48%1.15M	--1.21M	-83.40%365.94K
-Accrued interest receivable	----	----	----	----	--300.46K	--24.45K	----	----	----	----
-Other receivable	----	-16.40%986.1K	----	-3.88%1.1M	----	222.32%1.18M	----	-70.48%1.15M	----	-83.40%365.94K
Advance payment	46.82%4.53M	28.03%3.18M	61.35%3.54M	-36.72%2.64M	-38.57%3.09M	-68.37%2.48M	-74.10%2.19M	-21.29%4.17M	--5.03M	173.35%7.85M
Inventories	-22.37%24.2M	-19.14%25.19M	-14.23%27.03M	1.07%28.6M	10.62%31.17M	17.63%31.15M	57.13%31.51M	45.94%28.29M	--28.18M	10.14%26.48M
Receivable financing	----	----	124.87%775.79K	103.16%532.68K	--538.2K	--96.6K	--345K	45.67%262.2K	----	----
Other current assets	2,131.58%83.05M	1,769.64%79.6M	3,747.60%155.29M	3,188.94%129.43M	-32.36%3.72M	-32.07%4.26M	725.12%4.04M	642.81%3.94M	--5.5M	323.45%6.27M
Total current assets	-8.24%857.08M	-7.11%869.41M	-6.78%887.22M	-7.55%899.14M	-4.22%934.01M	-5.09%936.01M	-3.12%951.72M	244.23%972.58M	--975.12M	300.18%986.17M
Non Current assets
Fixed assets	----	-4.41%83.74M	----	-5.94%85.8M	----	-0.99%87.6M	----	9.43%91.21M	----	15.91%88.48M
Constru in process	----	--218.83K	----	----	----	----	----	----	----	----
Intangible assets	-4.45%466.94K	-4.07%524.25K	-33.55%401.57K	-32.06%449.89K	-31.31%488.7K	7.30%546.52K	9.26%604.33K	10.92%662.15K	--711.5K	-1.59%509.32K
Long deferred expense	-7.24%6.97M	-6.37%7.19M	126.02%7.81M	122.63%8.3M	82.45%7.51M	131.94%7.68M	-4.36%3.46M	-4.86%3.73M	--4.12M	152.73%3.31M
Deferred tax assets	3.54%13.14M	9.22%13.47M	14.99%13.34M	34.51%12.96M	154.71%12.69M	167.21%12.33M	198.59%11.6M	198.33%9.63M	--4.98M	21.92%4.62M
Usufruct assets	-36.49%4.84M	-33.38%5.53M	-30.86%6.23M	-28.65%6.92M	-9.03%7.62M	144.08%8.3M	134.15%9.01M	126.11%9.7M	--8.37M	-34.31%3.4M
Other non current assets	7,505.62%41.8M	5,130.29%41.41M	2,080.89%41.21M	3,314.34%41.15M	73.84%549.6K	-28.29%791.72K	0.37%1.89M	76.59%1.21M	--316.16K	83.34%1.1M
Adjustment items of non current assets	----	----	----	----	--0.01	--0.01	----	----	----	----
Total non current assets	30.35%148.21M	29.70%152.09M	33.97%153.61M	33.95%155.57M	2.05%113.71M	15.62%117.26M	13.07%114.66M	20.89%116.14M	--111.43M	15.61%101.42M
Total assets	-4.05%1.01B	-3.02%1.02B	-2.40%1.04B	-3.12%1.05B	-3.57%1.05B	-3.16%1.05B	-1.60%1.07B	187.56%1.09B	206.34%1.09B	225.47%1.09B
Liabilities
Current liabilities
Notes payable and accounts payable	-6.19%5.24M	-34.39%3.82M	7.44%3.91M	-64.03%4.09M	-44.09%5.58M	-71.42%5.82M	-78.26%3.63M	15.67%11.38M	--9.98M	172.18%20.37M
-Accounts payable	-6.19%5.24M	-34.39%3.82M	7.44%3.91M	-64.03%4.09M	-44.09%5.58M	-71.42%5.82M	-78.26%3.63M	15.67%11.38M	--9.98M	172.18%20.37M
Contract liabilities	-34.59%2.88M	-14.85%3.84M	-39.97%3.99M	-23.91%5.58M	-44.52%4.41M	-33.30%4.51M	-21.99%6.65M	-20.50%7.33M	--7.95M	-33.12%6.76M
Salaries payable	-3.65%9.3M	-12.79%8.95M	-23.49%8.34M	-24.33%12.89M	-22.65%9.65M	-12.34%10.27M	0.37%10.91M	27.54%17.04M	--12.47M	87.28%11.71M
Taxs payable	0.26%1.12M	12.93%1.05M	42.27%1.79M	-12.75%1.55M	-79.72%1.12M	-77.94%928.32K	-81.42%1.26M	-35.87%1.77M	--5.53M	251.73%4.21M
Other payable (including interest and dividends)	9.48%48.07M	4.78%52.16M	-5.83%51.88M	-7.11%51.28M	-18.75%43.9M	-4.20%49.79M	0.31%55.09M	89.82%55.2M	--54.03M	75.55%51.97M
-Other payable	----	4.78%52.16M	----	-7.11%51.28M	----	-4.20%49.79M	----	89.82%55.2M	----	75.55%51.97M
Non current liabilities due within one year	276.62%2.57M	45.99%2.91M	14.78%2.5M	12.48%2.93M	-64.27%683.71K	13.67%1.99M	36.74%2.18M	38.68%2.6M	--1.91M	62.99%1.75M
Other current liabilities	-35.70%111.35K	-1.49%139.82K	-11.35%147.41K	-5.28%131.79K	--173.17K	-58.80%141.94K	-67.61%166.28K	-17.71%139.14K	----	-49.06%344.48K
Total current liabilities	5.76%69.29M	-0.78%72.87M	-9.17%72.56M	-17.82%78.45M	-28.69%65.52M	-24.37%73.44M	-20.05%79.89M	43.97%95.46M	--91.88M	72.22%97.11M
Current liabilities
Estimate liabilities	576.40%31.61K	-87.81%3.14K	----	-74.14%11.8K	--4.67K	-82.43%25.79K	-82.11%42.28K	-81.05%45.63K	----	-78.22%146.82K
Deferred tax liabilities	----	----	----	----	--1.2M	--1.35M	--1.34M	--1.72M	----	----
Long term deferred income	-71.75%6.4M	-68.19%7.21M	-63.30%8.32M	-57.55%9.42M	2.09%22.66M	2.09%22.66M	2.09%22.66M	0.00%22.2M	--22.2M	4.23%22.2M
Lease liabilities	-67.35%2.29M	-53.44%2.8M	-42.30%3.88M	-48.28%4.09M	13.39%7.01M	223.77%6.01M	230.19%6.72M	274.34%7.91M	--6.18M	-48.36%1.86M
Total non current liabilities	-71.75%8.72M	-66.68%10.01M	-60.36%12.2M	-57.56%13.53M	8.79%30.88M	24.13%30.04M	25.71%30.76M	29.82%31.87M	--28.38M	-5.34%24.2M
Total liabilities	-19.07%78.02M	-19.91%82.88M	-23.40%84.76M	-27.77%91.97M	-19.84%96.4M	-14.69%103.49M	-11.05%110.65M	40.15%127.34M	46.15%120.26M	48.02%121.31M
Shareholders equity
Paid-in capital	0.00%40M	0.00%40M	0.00%40M	0.00%40M	0.00%40M	0.00%40M	0.00%40M	33.33%40M	--40M	33.33%40M
Capital reserve funds	-0.11%777.48M	-0.27%776.22M	-0.32%774.96M	-0.33%773.7M	-0.14%778.3M	-0.43%778.3M	-0.36%777.47M	473.13%776.23M	--779.37M	494.92%781.64M
Surplus reserve funds	13.60%12.92M	13.60%12.92M	13.60%12.92M	13.60%12.92M	0.00%11.38M	0.00%11.38M	0.00%11.38M	0.00%11.38M	--11.38M	89.52%11.38M
Retained profit	9.79%133.3M	11.20%132.96M	9.20%140.17M	1.27%136.46M	-10.18%121.41M	-10.34%119.56M	0.10%128.36M	20.94%134.75M	--135.18M	56.48%133.34M
Less:Treasury stock	--35.66M	--23.38M	--11.71M	----	----	----	----	----	----	----
Other composite income	-427.90%-763.28K	-119.07%-103.88K	81.17%-279.93K	64.06%-348.6K	-34.53%232.78K	722.06%544.82K	-191.95%-1.49M	-99.34%-969.95K	--355.56K	77.83%-87.58K
Shareholders equity without minority interests	-2.53%927.28M	-1.18%938.62M	0.04%956.07M	0.14%962.74M	-1.55%951.32M	-1.71%949.78M	-0.38%955.72M	234.11%961.38M	254.73%966.28M	283.13%966.27M
Total shareholder equity	-2.53%927.28M	-1.18%938.62M	0.04%956.07M	0.14%962.74M	-1.55%951.32M	-1.71%949.78M	-0.38%955.72M	234.11%961.38M	254.73%966.28M	283.13%966.27M
Total liabilityies and equity	-4.05%1.01B	-3.02%1.02B	-2.40%1.04B	-3.12%1.05B	-3.57%1.05B	-3.16%1.05B	-1.60%1.07B	187.56%1.09B	206.34%1.09B	225.47%1.09B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified opinion	--	--	--	--	--	--
Auditor	--	--	--	Lixin Certified Public Accountants (Special General Partnership)	--	--	--	Lixin Certified Public Accountants (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

688193 Shanghai Rendu Biotechnology

Shanghai Rendu Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target